Catalyst
Slingshot members are tracking this event:
Insys Therapeutics Enrolls First Patient in Phase II Study for the Treatment of Infantile Spasms Using Pharmaceutical CBD
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| INSY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 09, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2 Study, Trial Initiation, First Patient, Infantile Spasms, Is, Childhood Epilepsy, Seizure Control, Orphan Drug Designation, Pharmaceutical Cannabidiol, Cbd, Pediatric Epilepsy
